Showing results (41-50 of 93) with videos related to

Sort By:
Pageof 10
Leukemia|August 6, 2014
Mapping the HLA ligandome landscape of acute myeloid leukemia: a targeted approach toward peptide-based immunotherapyC Berlin, D J Kowalewski, H Schuster, et al.
Blood Cancer Journal|April 9, 2016
Carfilzomib alters the HLA-presented peptidome of myeloma cells and impairs presentation of peptides with aromatic C-terminiD J Kowalewski, S Walz, L Backert, et al.
Oncoimmunology|April 11, 2018
HLA ligandome analysis of primary chronic lymphocytic leukemia (CLL) cells under lenalidomide treatment confirms the suitability of lenalidomide for combination with T-cell-based immunotherapyAnnika Nelde, Daniel J Kowalewski, Linus Backert, et al.
Frontiers in Oncology|October 29, 2024
AML-VAC-XS15-01: protocol of a first-in-human clinical trial to evaluate the safety, tolerability and preliminary efficacy of a multi-peptide vaccine based on leukemia stem cell antigens in acute myeloid leukemia patientsSusanne Jung, Annika Nelde, Yacine Maringer, et al.
Genome Biology|September 22, 2025
MHCquant2 refines immunopeptidomics tumor antigen discoveryJonas Scheid, Steffen Lemke, Naomi Hoenisch-Gravel, et al.
Frontiers in Oncology|September 10, 2024
iVAC-XS15-CLL01: personalized multi-peptide vaccination in combination with the TLR1/2 ligand XS15 in CLL patients undergoing BTK-inhibitor-based regimensAlexander Englisch, Clara Hayn, Susanne Jung, et al.
Neuro-Oncology Advances|May 16, 2025
The immunopeptidomic landscape of ependymomas provides actionable antigens for T-cell-based immunotherapyLena Mühlenbruch, David Rieger, Hannes Becker, et al.
Oncogene|January 17, 2017
6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cellsS Ros, J Flöter, I Kaymak, et al.
Blood Cancer Journal|March 1, 2020
Mass spectrometry-based identification of a B-cell maturation antigen-derived T-cell epitope for antigen-specific immunotherapy of multiple myelomaTatjana Bilich, Annika Nelde, Jens Bauer, et al.
Iscience|November 28, 2022
Increased soluble HLA in COVID-19 present a disease-related, diverse immunopeptidome associated with T cell immunityAnnika Nelde, Jonas Rieth, Malte Roerden, et al.
Pageof 10